Description
Catheter-Related Bloodstream Infections (CRBSIs) Market size was valued at USD 1.4 billion in 2021, growing at a significant CAGR of 5.1% during 2022–2028. The global market is predicted to be driven by an increase in the prevalence of bloodstream infections. According to a study in the journal Continuing Education in Anaesthesia, Critical Care & Pain, catheter-related bloodstream infections happen in about 3% of catheterizations, although they can happen up to 16% of the time. Inaccurate diagnoses have serious consequences, including procedure difficulties that raise morbidity and mortality. Therefore, it is crucial to identify catheter-related bloodstream infections accurately. Moreover, the risk of CRBSI is elevated by hospital-acquired infections. According to the International Journal of Critical Illness and Injury Science, 10 to 20 percent of hospital-acquired infections in the United Kingdom are caused by CRBSI. The infrastructure for health care is being modernized by governments in developing nations, which is anticipated to expand access to healthcare. Additionally, healthcare-associated infections are a significant problem in underdeveloped countries. Therefore, the global market is presented with a huge potential due to the rise in demand for the items brought on by the patient population growth.
Reviews
There are no reviews yet.